Simavita Online Annual Report 2017

Directors’ Report for the year ended June 30, 2017 Directors The names of the Directors of Simavita Limited who held office during the year and to the date of this report are: Michael R Spooner Gary W Pace Warren R Bingham Company Secretary Peta C Jurd Sarah Prince (Co-Company Secretary) Ms. Sarah Prince was appointed Company Secretary on May 26, 2017 replacing Nathan Bartrop who resigned effective the same day. Ms. Prince is a solicitor and a member of the Governance Institute of Australia. She has been employed by Company Matters Pty Ltd as a Company Secretary and solicitor since 2006. Group Overview Simavita Limited is a public company incorporated in Canada and it is the Ultimate parent company for four wholly- owned subsidiaries: Simavita Holdings Limited Simavita (Aust) Pty Ltd Fred Bergman Healthcare Pty Ltd Simavita US Inc. Principal place of business Principal place of business for the Group is Level 13, 54 Miller Street, North Sydney NSW 2060 Australia. The country of incorporation of the ultimate parent and controlling entity of the Group is in Canada. Principal activities The Simavita Group of companies (the “Group”) is a world leader in the development of smart, wearable and disposable sensors for the global diaper industry. The Group is focused upon major and rapidly growing markets for adult and infant diapers which currently amount to over USD$21bn annually. The Group’s product range now encompasses a comprehensive spectrum of electronic sensors and systems from incontinence assessment through to everyday use including: –– SIM™ our traditional electronic incontinence assessment tool for large institutional users. –– AssessPLUS™ which was released to market in November 2016. AssessPLUS™ is a low cost, easy to use and highly graphical electronic assessment tool for community users including the NDIS through to aged care operators. –– AlertPLUS™ is our new core platform technology. AlertPLUS™ is a hyper low cost, completely disposable product linked to smart devices including phones and tablets. Our target market includes adult and infant users for all geographies. Simavita operates in Australia, Europe and North America where there is a significant and growing demand for products that deliver real clinical and cost benefits to the health care industry. The Directors submit their report on the consolidated entity consisting of Simavita Limited and the entities it controlled at the end of June 30, 2017. Simavita Limited 2017 Annual Report 10

RkJQdWJsaXNoZXIy MjE2NDg3